Day: November 2, 2023

Bíldudalur, 2nd of November 2023. Icelandic Salmon will be presenting results for the third quarter of 2023 on Thursday the 9th of November 2023. The presentation will be held at Arion Bank headquarters in Borgartún 19, 105 Reykjavík, in the conference room Þingvellir. The conference room will be open from: 8:00 Icelandic time(9:00 CEST)and company’s CEO Bjørn Hembre and CFO Jónas Heiðar Birgisson will be presenting the company’s results at 9:00 Icelandic time (10:00 CEST). The presentation will be held in English and also available via webcast. Everyone are welcome, and there is no registration needed to attend. To join remotely, please copy and paste the following link into your browser: arnarlax.webcast.is There will be opportunity to ask questions after the presentation or send in questions at questions@arnarlax.is. A recording...

Oma Savings Bank Plc Stock Exchange Release 2.11.2023          Oma Savings Bank Plc: Acquisition of own shares 2.11.2023     In the NASDAQ OMX Helsinki         Trade date 2.11.2023  Bourse trade Buy  Share OMASP  Amount 5,000 SharesAverage price/ share 20.5800 EURTotal cost 102,900.00 EUR          Company now holds a total of 177 488 shares  including the shares repurchased on 2.11.2023            On behalf of Oma Savings Bank Plc       Nordea Bank Finland Plc         Janne Sarvikivi Sami Huttunen            For further information, please contact:  Sarianna Liiri    CFO    Tel. +358 40 835 6712    sarianna.liiri@omasp.fi         Minna Sillanpää    CCO    Tel. +358 50 66592    minna.sillanpaa@omasp.fi         www.omasp.fi    ...

LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release third quarter 2023 financial results on Wednesday, November 8, 2023, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time. To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing...

Concord Pines of Ann Arbor by Toll BrothersToll Brothers announced the final opportunities to live at Concord Pines of Ann Arbor, including the stunning model home now offered for sale.Concord Pines of Ann Arbor by Toll Brothers“Concord Pines of Ann Arbor has seen tremendous interest among buyers from the start. Residents truly enjoy the new home offerings and incredible Ann Arbor location that provides a naturally private ambiance while still being so close to all of the convenience and fun of downtown,” said Isaac Boyd, Division President of Toll Brothers in Michigan.ANN ARBOR, Mich., Nov. 02, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to live in Concord Pines of Ann Arbor. Only three opportunities remain for home...

Hsinchu, Taiwan , Nov. 02, 2023 (GLOBE NEWSWIRE) — The automotive industry imposes stringent requirements on Functional Safety. For semiconductor companies involved in automotive chips and even further upstream in Silicon Intellectual Property (SIP), obtaining ISO 26262 certification is a fundamental requirement for product penetration into automotive applications. Andes Technology is actively developing a portfolio of automotive-grade IP products to enhance the efficiency of product functional safety verification activities. To streamline ISO 26262 verification and to integrate verification information conveniently, the decision was made to introduce Ansys medini to achieve the automation and modulization of safety analysis process. In the field of RISC-V CPU IP for the automotive market, Andes Technology has achieved remarkable...

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 11/02/2023.MCLEAN, Va., Nov. 02, 2023 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 7.76 percent. “The 30-year fixed-rate mortgage paused its multi-week climb but continues to hover under eight percent,” said Sam Khater, Freddie Mac’s Chief Economist. “The Federal Reserve again decided not to raise interest rates but have not ruled out a hike before year-end. Coupled with geopolitical uncertainty, this ambiguity around monetary policy will likely have an impact on the overall economic landscape and may continue to stall improvements in the housing market.” News Facts30-year fixed-rate mortgage averaged 7.76 percent as of...

HII Pentagon Metro CampaignA new HII targeted advertising campaign showcases the breadth of HII’s platforms, technologies and solutions across domains and services, in support of HII’s mission to deliver the advantage to its national defense customers.ARLINGTON, Va., Nov. 02, 2023 (GLOBE NEWSWIRE) — Which U.S. defense company is:The sole designer, builder and refueler of nuclear-powered aircraft carriers? The largest data platform provider for the U.S. Army? The largest supplier of surface combat ships to the U.S. Navy? The largest producer of unmanned underwater vehicles (UUV)? The leading provider of live, virtual, constructive (LVC) training for the U.S. military? The employer of more than 44,000 workers across 39 states, and the largest industrial employer in both Virginia and Mississippi?The answer is HII (NYSE:...

Brian Van Tine, M.D., of Washington University School of Medicine, shares data from the ongoing phase 1/2 KB-0742 clinical study that clearly corresponds with the findings from the pre-clinical studies at leading international sarcoma meeting KB-0742 demonstrated on-mechanism, single agent anti-tumor activity and a manageable safety profile in heavily pre-treated patients with transcriptionally addicted solid tumors   SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced the presentation of positive preliminary data from the phase 1 dose escalation portion of the ongoing phase 1/2 KB-0742 study at the Connective Tissue Oncology Society annual meeting in Dublin, Ireland. Today’s presentation...

Name change reinforces a fresh start for chronic wounds with a triple threat approachrevyve™ Antimicrobial Wound Gelrevyve™ Antimicrobial Wound GelWINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today announces the launch of the newly rebranded revyve™ Antimicrobial Wound Gel (formerly coactiv+™ Antimicrobial Wound Gel). “We are excited to share this cutting-edge product and the new revyve™ brand with the larger wound care community. Clinicians who have been exposed to the product so far have really appreciated the combination of advanced technology with an affordable price point. We are working to expand clinical usage of the product in advance...